Analysis of drug resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in children with urinary tract infection

References

1. ↵
   1. Keren R,
   2. Shaikh N,
   3. Pohl H,
   4. Gravens-Mueller L,
   5. Ivanova A,
   6. Zaoutis L,
   7. et al.

   (2015) Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics 136:13–21.

   OpenUrl
2. ↵
   1. Stein R,
   2. Dogan HS,
   3. Hoebeke P,
   4. Kočvara R,
   5. Nijman RJM,
   6. Radmayr C,
   7. et al.

   (2015) Urinary tract infections in children:EAU/ESPU guidelines. Eur Urol 67:546–558.

   OpenUrlCrossRefPubMed
3. ↵
   1. Castanheira M,
   2. Mills JC,
   3. Costello SE,
   4. Jones RN,
   5. Sader HS

   (2015) Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from US hospitals (2011 to 2013) and characterization of β-lactamase-producing strains. Antimicrob Agents Chemother 59:3509–3517.

   OpenUrlAbstract/FREE Full Text
4. ↵
   1. Conover MS,
   2. Hadjifrangiskou M,
   3. Palermo JJ,
   4. Hibbing ME,
   5. Dodson KW,
   6. Hultgren SJ

   (2016) Metabolic requirements of Escherichia coli in intracellular bacterial communities during urinary tract infection pathogenesis. MBio 7:e00104–e00116.

   OpenUrlCrossRef
5. ↵
   1. Goyal D,
   2. Dean N,
   3. Neill S,
   4. Jones P,
   5. Dascomb K

   (2019) Risk factors for community-acquired extended-spectrum beta-lactamase-producing Enterobacteriaceae infections-a retrospective study of symptomatic urinary tract infections. Open Forum Infect Dis 6:357.

   OpenUrl
6. ↵
   1. Morrissey I,
   2. Hackel M,
   3. Badal R,
   4. Bouchillon S,
   5. Hawser S,
   6. Biedenbach D

   (2013) A review of ten years of the study for monitoring antimicrobial resistance trends (SMART) from 2002 to 2011. Pharmaceuticals 6:1335–1346.

   OpenUrl
7. ↵
   1. Vega S,
   2. Dowzicky MJ

   (2017) Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the tigecycline evaluation and surveillance trial. Ann Clin Microbiol Antimicrob 16:50.

   OpenUrlCrossRef
8. ↵
   1. Zilberberg MD,
   2. Shorr AF

   (2013) Secular trends in Gram-negative resistance among urinary tract infection hospitalizations in the United States 2000-2009. Infect Control Hosp Epidemiol 34:940–946.

   OpenUrlCrossRefPubMed
9. ↵
   1. Hsu AJ,
   2. Tamma PD

   (2014) Treatment of multidrug-resistant Gramnegative infections in children. Clin Infect Dis 58:1439–1448.

   OpenUrlCrossRefPubMed
10. ↵
    1. Gupta K,
    2. Bhadelia N

    (2014) Management of urinary tract infections from multidrug-resistant organisms. Infect Dis Clin North Am 28:49–59.

    OpenUrlCrossRefPubMed
11. ↵
    1. Delbet JD,
    2. Lorrot M,
    3. Ulinski T

    (2017) An update on new antibiotic prophylaxis and treatment for urinary tract infections in children. Expert Opin Pharmacother 18:1619–1625.

    OpenUrl
12. 1. Bader MS,
    2. Loeb M,
    3. Brooks AA

    (2017) An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med 129:242–258.

    OpenUrlCrossRef
13. ↵
    1. Lob SH,
    2. Hackel MA,
    3. Hoban DJ,
    4. Young K,
    5. Motyl MR,
    6. Sahm DF,
    7. et al.

    (2018) Activity of Ertapenem against Enterobacteriaceae in seven global regions-SMART 2012-2016. Eur J Clin Microbiol Infect Dis 37:1481–1489.

    OpenUrl
14. ↵
    1. Hoban DJ,
    2. Lascols C,
    3. Nicolle LE,
    4. Badal R,
    5. Bouchillon S,
    6. Hackel M,
    7. et al.

    (2012) Antimicrobial susceptibility of Enterobacteriaceae including molecular characterization of extended - spectrum beta - lactamase - producing species, in urinary tract isolates from hospitalized patients in North America and Europe:results from the SMART study 2009-2010. Diagn Microbiol Infect Dis 74:62–67.

    OpenUrlCrossRefPubMed
15. ↵
    1. Munoz-Davila MJ

    (2014) Role of old antibiotics in the era of antibiotic resistance highlighted nitrofurantoin for the treatment of lower urinary tract infections. Antibiotics (Basel) 10:39–48.

    OpenUrl
16. ↵
    1. Vélez EC,
    2. Serna-Higuita LM,
    3. Serrano AK,
    4. Ochoa-García C,
    5. Rojas Rosas L,
    6. María Bedoya A,
    7. et al.

    (2014) Resistance profile of pathogens causing urinary tract infection in the pediatric population, and antibiotic treatment response, at a University Hospital 2010-2011. Colomb Med (Cali) 45:39–44.

    OpenUrl